| Dianna M Clyne, MD | |
|
4444 South 86th St, Suite 102, Lincoln, NE 68526-9253 | |
| (402) 476-7557 | |
| (402) 769-9912 |
| Full Name | Dianna M Clyne |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 35 Years |
| Location | 4444 South 86th St, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114035938 | NPI | - | NPPES |
| 345911000 | Other | NE | MAGELLAN |
| 35147 | Other | NE | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 18318 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryan Medical Center | Lincoln, NE | Hospital |
| Entity Name | Dianna Clyne Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164618666 PECOS PAC ID: 6406876606 Enrollment ID: O20051202000334 |
News Archive
New research from UC San Francisco shows that an "expressive therapy" group intervention conducted by The Medea Project helps women living with HIV disclose their health status and improves their social support, self-efficacy and the safety and quality of their relationships.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
It is important that the United States begin to live within its means and address the federal deficit. But APS believes that as a nation we need to be smart about how we do it. Cutting spending across the board without a clear understanding of what it means for America's future jeopardizes the very future we want to secure for our children.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dianna M Clyne, MD 4444 South 86th St, Suite 102, Lincoln, NE 68526-9253 Ph: (402) 476-7557 | Dianna M Clyne, MD 4444 South 86th St, Suite 102, Lincoln, NE 68526-9253 Ph: (402) 476-7557 |
News Archive
New research from UC San Francisco shows that an "expressive therapy" group intervention conducted by The Medea Project helps women living with HIV disclose their health status and improves their social support, self-efficacy and the safety and quality of their relationships.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
It is important that the United States begin to live within its means and address the federal deficit. But APS believes that as a nation we need to be smart about how we do it. Cutting spending across the board without a clear understanding of what it means for America's future jeopardizes the very future we want to secure for our children.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
› Verified 5 days ago
Stephanie Sutton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 550 N 19th St, Lincoln, NE 68588 Phone: 402-472-5000 | |
Dr. Walter J Duffy, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8101 O St, Suite 300, Lincoln, NE 68510 Phone: 402-476-6060 Fax: 402-476-6809 | |
Soa Yuc Lee, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 600 S 70th St, Lincoln, NE 68510 Phone: 402-489-3802 | |
Michael William Vavra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2222 S 16th St Ste 340, Lincoln, NE 68502 Phone: 402-483-8534 Fax: 402-483-8531 | |
Zakaria Siddiqui, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2221 S 17th St, Suite 202, Lincoln, NE 68502 Phone: 402-483-8555 Fax: 402-483-8554 | |
Ana Luisa Delgado, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7441 O St Ste 104, Lincoln, NE 68510 Phone: 402-853-0993 Fax: 402-853-0197 |